(Q39881718)

15 September 2017

title

R-roscovitine sensitizes anaplastic thyroid carcinoma cells to TRAIL-induced apoptosis via regulation of IKK/NF-kappaB pathway (English)

1 reference

anaplastic thyroid carcinoma

15 September 2017

0 references

1 reference

1 reference

Michela Festa

1

1 reference

15 September 2017

Antonello Petrella

series ordinal

2

1 reference

15 September 2017

Silvia Alfano

series ordinal

3

1 reference

15 September 2017

Luca Parente

series ordinal

4

1 reference

15 September 2017

language of work or name

English

0 references

publication date

1 June 2009

1 reference

International Journal of Cancer

15 September 2017

published in

1 reference

15 September 2017

volume

124

1 reference

15 September 2017

issue

11

1 reference

15 September 2017

page(s)

2728-2736

1 reference

Management of thyroid cancer

15 September 2017

cites work

1 reference

To cycle or not to cycle: a critical decision in cancer.

21 January 2018

1 reference

The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer

21 January 2018

1 reference

CDK inhibitors in cancer therapy: what is next?

21 January 2018

1 reference

Bioluminescent imaging of Cdk2 inhibition in vivo

21 January 2018

1 reference

A phase I trial of the selective oral cyclin-dependent kinase inhibitor seliciclib (CYC202; R-Roscovitine), administered twice daily for 7 days every 21 days

21 January 2018

1 reference

Cyclin-dependent kinase inhibitors enhance the resolution of inflammation by promoting inflammatory cell apoptosis

21 January 2018

1 reference

Apo2L/TRAIL and its death and decoy receptors

21 January 2018

1 reference

Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo.

21 January 2018

1 reference

Nuclear factor-kappaB in cancer development and progression

21 January 2018

1 reference

Control of apoptosis by Rel/NF-kappaB transcription factors

21 January 2018

1 reference

Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB.

21 January 2018

1 reference

NF-kappaB at the crossroads of life and death

21 January 2018

1 reference

An essential role for NF-kappaB in preventing TNF-alpha-induced cell death

21 January 2018

1 reference

Aberrant rel/nfkb genes and activity in human cancer

21 January 2018

1 reference

Expression of the neoplastic phenotype by human thyroid carcinoma cell lines requires NFkappaB p65 protein expression.

21 January 2018

1 reference

Oncogenic and anti-apoptotic activity of NF-kappa B in human thyroid carcinomas

21 January 2018

1 reference

Inhibition of nuclear factor-kappaB cascade potentiates the effect of a combination treatment of anaplastic thyroid cancer cells

21 January 2018

1 reference

R-Roscovitine simultaneously targets both the p53 and NF-kappaB pathways and causes potentiation of apoptosis: implications in cancer therapy.

21 January 2018

1 reference

Roscovitine sensitizes glioma cells to TRAIL-mediated apoptosis by downregulation of survivin and XIAP.

21 January 2018

1 reference

Roscovitine sensitizes breast cancer cells to TRAIL-induced apoptosis through a pleiotropic mechanism

21 January 2018

1 reference

Dexamethasone inhibits TRAIL-induced apoptosis of thyroid cancer cells via Bcl-xL induction.

21 January 2018

1 reference

Effects of FR235222, a novel HDAC inhibitor, in proliferation and apoptosis of human leukaemia cell lines: role of annexin A1.

21 January 2018

1 reference

Inhibition of nuclear translocation of transcription factor NF-kappa B by a synthetic peptide containing a cell membrane-permeable motif and nuclear localization sequence

21 January 2018

1 reference

Altered expression of c-IAP1, survivin, and Smac contributes to chemotherapy resistance in thyroid cancer cells.

21 January 2018

1 reference

Pathogenetic mechanisms in thyroid follicular-cell neoplasia

21 January 2018

1 reference

ABT-737 induces expression of the death receptor 5 and sensitizes human cancer cells to TRAIL-induced apoptosis

21 January 2018

1 reference

Interleukin-1beta and tumor necrosis factor (TNF)-alpha sensitize human thyroid epithelial cells to TNF-related apoptosis-inducing ligand-induced apoptosis through increases in procaspase-7 and bid, and the down-regulation of p44/42 mitogen-activate

21 January 2018

1 reference

Quercetin augments TRAIL-induced apoptotic death: involvement of the ERK signal transduction pathway

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.24260

1 reference

15 September 2017

1 reference